Page last updated: 2024-11-12

gw1100

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

GW1100: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11692123
CHEMBL ID4303679
SCHEMBL ID12180353
MeSH IDM0504926

Synonyms (21)

Synonym
HY-50691
gw1100
gw-1100
ethyl 4-[5-[(2-ethoxypyrimidin-5-yl)methyl]-2-[(4-fluorophenyl)methylsulfanyl]-4-oxopyrimidin-1-yl]benzoate
gw 1100
gtpl1057
cid 11692123
SCHEMBL12180353
CS-0280
AKOS016359129
306974-70-9
AC-33178
DTXSID80470686
gpr40 antagonist, gw1100 - cas 306974-70-9
benzoic acid, 4-[5-[(2-ethoxy-5-pyrimidinyl)methyl]-2-[[(4-fluorophenyl)methyl]thio]-4-oxo-1(4h)-pyrimidinyl]-, ethyl ester
ethyl 4-(5-((2-ethoxypyrimidin-5-yl)methyl)-2-((4-fluorobenzyl)thio)-4-oxopyrimidin-1(4h)-yl)benzoate
Q27077936
CHEMBL4303679
A924770
F83494
MS-29654

Research Excerpts

Treatment

ExcerptReferenceRelevance
"GW1100 pretreatment, however, prevented lipid-rescue, with no recovery after 10 min."( Free Fatty Acid Receptor G-protein-coupled Receptor 40 Mediates Lipid Emulsion-induced Cardioprotection.
Cunningham, CM; Eghbali, M; Hannabass, K; Li, J; Mahajan, A; Moazeni, S; Umar, S; Vaillancourt, M, 2018
)
1.2
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1345809Human FFA1 receptor (Free fatty acid receptors)2007Molecular pharmacology, Apr, Volume: 71, Issue:4
Uncovering the pharmacology of the G protein-coupled receptor GPR40: high apparent constitutive activity in guanosine 5'-O-(3-[35S]thio)triphosphate binding studies reflects binding of an endogenous agonist.
AID1345809Human FFA1 receptor (Free fatty acid receptors)2006British journal of pharmacology, Jul, Volume: 148, Issue:5
Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (9.09)29.6817
2010's15 (68.18)24.3611
2020's5 (22.73)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.69

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.69 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index5.70 (4.65)
Search Engine Demand Index66.70 (26.88)
Search Engine Supply Index4.00 (0.95)

This Compound (30.69)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]